Highlight Therapeutics
Spain - ValenciaBiotechnology
Focus: Highlight Therapeutics is a newly-founded (2024) Spanish biotech focused on immuno-oncology via synthetic dsRNA complexes. The company is early-stage with a public listing but minimal operational history.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Highlight Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Highlight Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Part 1: BO-112
CancerClinical Trials (1)
NCT02828098Exploratory Study of BO-112 in Adult Patients With Aggressive Solid Tumors
Phase 1Help build intelligence for Highlight Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.